CureledgerCureledger
ReferencesBlog
Join

Blog

The case for patient-controlled rare disease data across science, policy, and the lived experience.

Featured

Patient Experience

What the system tells us

Nine sentences inherited from a different era.

Read →

This week

Patient Experience

What we still have to do

The structural friction of rare disease daily life.

Read →
Data Sovereignty

Unpaid data farmers

The data work we have been doing for free, finally compensated.

Read →
Vision

The flywheel

Cohort proof licensed. Contribution measured. Deposit lands.

Read →

Search articles

Browse by tag

Clear ×
Patient ExperienceData SovereigntyVisionScience & DataRegulatoryUltra-rareAccelerating innovationEhlers-DanlosNewborn screeningCompanyHistory
Read all4 of 117 · Tag: Patient Experience
↓
  1. Jul 27, 2026What the system tells usPatient Experience
  2. Jul 20, 2026What we still have to doPatient Experience
  3. Jun 15, 2026Reviews are the doorPatient Experience
  4. Apr 22, 2026What "Best Case" Looks Like in Rare DiseasePatient Experience
About·For investors·Privacy··

© 2026 Cureledger Inc. · Raleigh, NC USA